SCHEMBL144532

SCHEMBL144532

CC(C)(C)c1ccc(CCl)c2cccnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.42
NPC1 O15118 5/20 0.42
L3MBTL1 Q9Y468 5/20 0.42
HTT P42858 3/20 0.42
RAB9A P51151 3/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALOX12 P18054 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSP90AA1 P07900 1/20 0.39
PAX8 Q06710 1/20 0.38
BRD4 O60885 3/20 0.38
MITF O75030 1/20 0.38
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.36
ALOX15 P16050 2/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24617752 0.85 KDM4E (0.44) KDM4ENPC1L3MBTL1HTTRAB9A
SCHEMBL14336996 0.81 HSP90AA1 (0.48) KDM4ENPC1L3MBTL1HTTLMNA
SCHEMBL112362 0.78 BRD4 (0.45) KDM4ENPC1L3MBTL1HTTRAB9A
SCHEMBL12201788 0.78 KDM4E (0.56) KDM4ENPC1L3MBTL1HTTLMNA
SCHEMBL11891548 0.78 KMT2A (0.59) KDM4ENPC1L3MBTL1HTTSMN1; SMN2
SCHEMBL25958897 0.76 HTT (0.58) KDM4ENPC1L3MBTL1HTTLMNA
SCHEMBL112193 0.75 KDM4E (0.74) KDM4ENPC1L3MBTL1HTTRAB9A
SCHEMBL13437149 0.75 SLC40A1 (0.49) KDM4ENPC1L3MBTL1HSP90AA1PAX8
SCHEMBL13437131 0.75 KDM4E (0.56) KDM4ENPC1L3MBTL1HTTLMNA
SCHEMBL20524033 0.74 NCF1 (0.48) KDM4ELMNAALOX12MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058945-A1 NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2012-03-08 US disclosed
US-8058442-B2 Neuroprotective iron chelators and pharmaceutical compositions comprising them TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2011-11-15 US disclosed
US-20060234927-A1 Neuroprotective iron chelators and pharmaceutical compositions comprising them TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2006-10-19 US disclosed
EP-1565185-A2 NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2005-08-24 EP disclosed
WO-2004041151-A2 NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2004-05-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058945-A1 NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FECH, HMOX1, FTH1 KDM4E 3494/4885NPC1 1211/4885L3MBTL1 908/4885
US-20060234927-A1 Neuroprotective iron chelators and pharmaceutical compositions comprising them FECH, HMOX1, FTH1 KDM4E 3557/4885NPC1 1104/4885L3MBTL1 1041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.